BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15550290)

  • 1. Changing the world: the design and implementation of comprehensive continuous integrated systems of care for individuals with co-occurring disorders.
    Minkoff K; Cline CA
    Psychiatr Clin North Am; 2004 Dec; 27(4):727-43. PubMed ID: 15550290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correctional treatment for co-occurring disorders: results of a national survey.
    Peters RH; LeVasseur ME; Chandler RK
    Behav Sci Law; 2004; 22(4):563-84. PubMed ID: 15282840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creating an integrated health care system: the health and human risk management model.
    Bergmark RE; Dell P; Attridge M; Parker M
    Manag Care Q; 1996; 4(1):36-42. PubMed ID: 10154064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substance abuse with mental disorders: specialized public systems and integrated care.
    Burnam MA; Watkins KE
    Health Aff (Millwood); 2006; 25(3):648-58. PubMed ID: 16684728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grant award to the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska. Center for Substance Abuse Treatment (CSAT), Center for Mental Health Services (CMHS), Substance Abuse and Mental Health Services Administration (SAMHSA), HHS. Availability of grant funds for the Division of Mental Health and Developmental Disabilities, Department of Health and Social Services, State of Alaska.
    Fed Regist; 1999 Apr; 64(73):18922-3. PubMed ID: 10558551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SAMHSA releases revised and updated treatment improvement protocol on co-occurring disorders.
    Psychiatr Serv; 2005 Mar; 56(3):371. PubMed ID: 15816109
    [No Abstract]   [Full Text] [Related]  

  • 9. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional planning implementation and its impact on integration of a mental health care network.
    Fleury MJ; Mercier C; Denis JL
    Int J Health Plann Manage; 2002; 17(4):315-32. PubMed ID: 12476640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing an integrated substance use and mental health service in the specialised setting of a youth detention centre.
    Stathis SL; Letters P; Doolan I; Whittingham D
    Drug Alcohol Rev; 2006 Mar; 25(2):149-55. PubMed ID: 16627304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mental illness and substance use: an Australian perspective.
    Munro I; Edward KL
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Policy and practice implications of epidemiological surveys on co-occurring mental and substance use disorders.
    Clark HW; Power AK; Le Fauve CE; Lopez EI
    J Subst Abuse Treat; 2008 Jan; 34(1):3-13. PubMed ID: 17574794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing integrated treatment for co-existing substance use and severe mental health problems in assertive outreach teams: training issues.
    Graham HL
    Drug Alcohol Rev; 2004 Dec; 23(4):463-70. PubMed ID: 15763751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using NIATx strategies to implement integrated services in routine care: a study protocol.
    Ford JH; Osborne EL; Assefa MT; McIlvaine AM; King AM; Campbell K; McGovern MP
    BMC Health Serv Res; 2018 Jun; 18(1):431. PubMed ID: 29884164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and initial feasibility of an organizational measure of behavioral health integration in medical care settings.
    McGovern MP; Urada D; Lambert-Harris C; Sullivan ST; Mazade NA
    J Subst Abuse Treat; 2012 Dec; 43(4):402-9. PubMed ID: 22999813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological trauma and substance abuse: the need for an integrated approach.
    Dass-Brailsford P; Myrick AC
    Trauma Violence Abuse; 2010 Oct; 11(4):202-13. PubMed ID: 20823072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.